Genzyme puts another $23M into Alnylam as major investors come calling

Alnylam Pharmaceuticals announced today that Genzyme Corp. has bought another $23 million worth of stock to maintain its 12-percent ownership stake in the firm as federal filings show that other investors have bought significant shares in the company in the past two months as well...